• Lactate-Driven Ran Lactylation Regulates Astrocyte Polarizat

  2026-04-23

  This study uncovers a mechanism by which lactate accumulation after spinal cord injury induces lactylation of the Ran GTPase at lysine 123, promoting astrocyte polarization via STAT3 nuclear transport. The research highlights SIRT1's regulatory role in this non-histone lactylation process, advancing understanding of metabolic-epigenetic crosstalk in CNS injury repair.

• Eltanexor (KPT-8602): Advancing XPO1 Inhibition in Cancer Re

  2026-04-23

  Eltanexor (KPT-8602), a second-generation, orally bioavailable XPO1 inhibitor, is redefining cancer therapeutics by targeting nuclear export with heightened precision and tolerability. This article blends mechanistic insights into XPO1-mediated oncogenesis with strategic guidance for translational researchers, spotlighting Eltanexor’s validated impact on acute myeloid leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and emerging opportunities in colorectal cancer chemoprevention. We contextualize these advances within the evolving competitive landscape and provide protocols and actionable outlooks, positioning APExBIO’s Eltanexor as a catalyst for innovative translational workflows.

• Scenario-Driven Best Practices with JNJ-26854165 (Serdemetan

  2026-04-22

  This article provides a scenario-driven, evidence-based playbook for cell viability and apoptosis assays leveraging JNJ-26854165 (Serdemetan) (SKU A4204). Drawing on published data and real-world laboratory challenges, we demonstrate how this HDM2 ubiquitin ligase antagonist from APExBIO supports reproducible, high-confidence results in cancer research.

• EZ Cap Cy5 Firefly Luciferase mRNA: Quantitative Tracking &

  2026-04-22

  Explore how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) enables quantitative mRNA delivery tracking and assay optimization. Discover unique workflow insights, microfluidic manufacturing advances, and practical protocols for dual-mode bioluminescence and fluorescence applications.

• Dual-Network Hydrogel Microspheres Mitigate IVDD via Apoptos

  2026-04-21

  This study introduces a multifunctional dual-network hydrogel microsphere system for targeted delivery of miR-155 and chitooligosaccharide to nucleus pulposus cells (NPCs), effectively reducing inflammation and apoptosis in intervertebral disc degeneration (IVDD) models. The findings highlight a promising approach for addressing the complex pathophysiology of IVDD by combining mechanical support, controlled drug release, and modulation of key degenerative pathways.

• Valemetostat in Lymphoma Research: Protocols, Use Cases & Pr

  2026-04-21

  Valemetostat (DS-3201) delivers robust, selective inhibition of EZH2—including clinically relevant Y641, A677, and A687 mutants—enabling advanced epigenetic cancer therapy and reproducible results in lymphoma models. This guide dissects practical workflows, data-driven troubleshooting, and experimental advantages, mapping reference-backed innovation to actionable laboratory protocols.

• Technical Guide: Angiotensin I/II (1-5) in RAS Workflows

  2026-04-20

  Angiotensin I/II (1-5) offers researchers a defined Asp-Arg-Val-Tyr-Ile peptide fragment specifically for modeling blood pressure regulation and aldosterone release within the renin-angiotensin system. It is appropriate for cardiovascular and renal physiology workflows, but should not be used in unrelated peptide or signaling studies due to its narrow mechanistic scope.

• PP2A-Driven Autophagy and Drug Resistance in Candida albican

  2026-04-20

  This article examines how protein phosphatase 2A (PP2A) modulates autophagy-related protein phosphorylation to enhance biofilm formation and drug resistance in Candida albicans. The findings clarify a mechanistic link between autophagy and antifungal resistance, supporting new strategies for targeting biofilm-associated infections.

• 5-hme-dCTP: Precision Epigenetic DNA Modification in Plants

  2026-04-19

  Unlock next-generation epigenetic DNA modification research with 5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate). This guide translates breakthrough plant drought response findings into actionable workflows, troubleshooting tips, and strategic assay enhancements—enabling researchers to dissect DNA hydroxymethylation dynamics with unprecedented resolution.

• Piezo2-Driven Neuroinflammation in Trigeminal Neuralgia Allo

  2026-04-18

  Liao et al. reveal that chronic compression of the trigeminal root induces a neuroinflammatory cascade, linking ATP-driven Ca2+ signaling to upregulation of Piezo2 and neuropeptides CGRP and SP in trigeminal neuralgia (TN). This study clarifies a mechanistic positive feedback loop that underlies mechanical allodynia, offering new molecular targets for pain management research.

• ApexPrep DNA Plasmid Miniprep Kit: Precision DNA for Advance

  2026-04-17

  Discover how the ApexPrep DNA Plasmid Miniprep Kit delivers molecular biology grade plasmid DNA for high-stakes applications in acute myeloid leukemia (AML) research. This article provides a unique, evidence-driven analysis of workflow optimization, reference-based assay design, and critical decision points for translational science.

• Probenecid: Precision Tool for Multidrug Resistance and Neur

  2026-04-16

  Probenecid (4-(dipropylsulfamoyl)benzoic acid) stands out as a dual-action research reagent, enabling both multidrug resistance reversal in tumor models and neuroprotection in ischemia/reperfusion injury workflows. This guide demystifies its integration into advanced protocols, offering stepwise experimental strategies and practical troubleshooting informed by the latest literature.

• Practical Guide to Dimethyloxalylglycine (DMOG) Use in Hypox

  2026-04-15

  Dimethyloxalylglycine (DMOG) is a cell-permeable inhibitor that enables controlled hypoxia-inducible factor (HIF) stabilization, supporting hypoxia signaling and inflammation research in vitro and in vivo. This compound is best suited for mechanistic studies where precise, reversible PHD inhibition and HIF-1α stabilization are required. It should not be used for diagnostic or therapeutic applications.

• Oligomycin A: Precision Mitochondrial ATP Synthase Inhibitio

  2026-04-14

  Oligomycin A, a gold-standard mitochondrial ATP synthase inhibitor from APExBIO, unlocks advanced control over mitochondrial bioenergetics and metabolic adaptation assays. This guide delivers actionable protocols, troubleshooting strategies, and practical insights—bridging cutting-edge immunometabolic findings with reproducible experimental workflows.

• Toremifene in Prostate Cancer: Applied Workflows & Key Innov

  2026-04-13

  Toremifene, a potent selective estrogen-receptor modulator, empowers researchers to dissect hormone-dependent cancer pathways and calcium signaling in advanced prostate cancer models. This article translates cutting-edge findings on the TSPAN18-STIM1 axis into actionable protocols, troubleshooting guidance, and strategic advantages for hormone-responsive cancer research.

16456 records 1/1098 page Next 12345 下5页 Last page